Preclinical pharmacokinetic characterization of 2-(4-(4-(5-(2-phenyl-5-(trifluoromethyl)oxazole-4-carboxamido)-1H-benzo[d]imidazol-2-yl)phenyl)cyclohexyl) acetic acid, a novel DGAT-1 inhibitor. [electronic resource]
Producer: 20150526Description: 465-71 p. digitalISSN:- 1366-5928
- Acetates -- metabolism
- Animals
- Benzimidazoles -- metabolism
- Blood Proteins -- metabolism
- Caco-2 Cells -- drug effects
- Diacylglycerol O-Acyltransferase -- antagonists & inhibitors
- Dose-Response Relationship, Drug
- Enzyme Inhibitors -- pharmacokinetics
- Humans
- Inactivation, Metabolic
- Intestinal Absorption
- Male
- Microsomes, Liver -- drug effects
- Permeability
- Rats
- Rats, Sprague-Dawley
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.